Boxer Capital, LLC
- SEC CIK
- 0001465837
- Latest filing
- Feb 14, 2025
APLS holding history
Apellis Pharmaceuticals, Inc. in every 13F filed by Boxer Capital, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
APLS overviewAll 13F holders of APLSFull Q4 2024 holdings
- Shares (Q4 2024)
- 0
- Sold out in Q4 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 11
- Since Q1 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2024 | 0 | $0 | 0.0% | −1,726,000−100.0% | Sold out | Holders |
| Q3 2024 | 1,726,000 | $49.8M | 2.4% | 00.0% | Unchanged | Holders |
| Q2 2024 | 1,726,000 | $66.2M | 3.5% | 00.0% | Unchanged | Holders |
| Q1 2024 | 1,726,000 | $101.5M | 5.0% | 00.0% | Unchanged | Holders |
| Q4 2023 | 1,726,000 | $103.3M | 5.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 1,726,000 | $65.7M | 3.5% | +150,000+9.5% | Added | Holders |
| Q2 2023 | 1,576,000 | $143.6M | 6.7% | 00.0% | Unchanged | Holders |
| Q1 2023 | 1,576,000 | $104.0M | 5.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 1,576,000 | $81.5M | 4.4% | +272,300+20.9% | Added | Holders |
| Q3 2022 | 1,303,700 | $89.0M | 5.0% | 00.0% | Unchanged | Holders |
| Q2 2022 | 1,303,700 | $59.0M | 3.7% | 00.0% | Unchanged | Holders |
| Q1 2022 | 1,303,700 | $66.2M | 3.4% | +1,303,700 | New | Holders |